There is an increasing body of literature suggesting that mindfulness training may be efficacious in treatment of substance use disorders.
There is an increasing body of literature suggesting that mindfulness training may be efficacious in treatment of substance use disorders.
l
Bowen and colleagues set out to conduct the first randomized, controlled trial which would allow for a scientifically-sound comparison between mindfulness-based relapse prevention, cognitive-behavioral relapse prevention or treatment as usual.
The mindfulness-based relapse prevention intervention consisted of 8 weekly, 2-hour group sessions with 2 therapists. The first few sessions provided patients with a foundation in mindfulness and subsequent sessions focused on mindfulness practices, self-care and social support. The cognitive-behavioral relapse prevention intervention was similar to the mindfulness-based program with respect to treatment dose, environment and expectations (e.g. amount of homework).
Topics included:
The treatment as usual condition was a 12-step abstinence-based open-formal group treatment that consisted primarily of discussions. These groups were held 1-2 times per week for 1.5 hours.
To assess the relative efficacy of mindfulness-based relapse prevention, the researchers compared time to relapse (drug use or heavy drinking) between groups over 1 year. Compared to the 12-step abstinence-based group, the mindfulness and cognitive-behavioral relapse prevention groups showed a 54-59% decreased risk of relapse.
Key Findings Included:
The cognitive-behavioral relapse prevention group was most efficacious in extending time to relapse post-treatment. Both the cognitive-behavioral and the mindfulness-based relapse prevention group showed greater odds of reducing relapse risk as compared to the 12-step abstinence-based group treatment. As time progressed, the treatment condition did not appear to be important in terms of substance use outcomes (6 months) until the 1-year mark at which point the mindfulness-based relapse prevention group appeared to be the most efficacious at reducing drug use and heavy drinking. When considered together, this research suggests that relapse prevention groups are efficacious in reducing relapse risk, however the relative benefits may differ in the short- vs. long-term.
l
Bowen and colleagues set out to conduct the first randomized, controlled trial which would allow for a scientifically-sound comparison between mindfulness-based relapse prevention, cognitive-behavioral relapse prevention or treatment as usual.
The mindfulness-based relapse prevention intervention consisted of 8 weekly, 2-hour group sessions with 2 therapists. The first few sessions provided patients with a foundation in mindfulness and subsequent sessions focused on mindfulness practices, self-care and social support. The cognitive-behavioral relapse prevention intervention was similar to the mindfulness-based program with respect to treatment dose, environment and expectations (e.g. amount of homework).
Topics included:
The treatment as usual condition was a 12-step abstinence-based open-formal group treatment that consisted primarily of discussions. These groups were held 1-2 times per week for 1.5 hours.
To assess the relative efficacy of mindfulness-based relapse prevention, the researchers compared time to relapse (drug use or heavy drinking) between groups over 1 year. Compared to the 12-step abstinence-based group, the mindfulness and cognitive-behavioral relapse prevention groups showed a 54-59% decreased risk of relapse.
Key Findings Included:
The cognitive-behavioral relapse prevention group was most efficacious in extending time to relapse post-treatment. Both the cognitive-behavioral and the mindfulness-based relapse prevention group showed greater odds of reducing relapse risk as compared to the 12-step abstinence-based group treatment. As time progressed, the treatment condition did not appear to be important in terms of substance use outcomes (6 months) until the 1-year mark at which point the mindfulness-based relapse prevention group appeared to be the most efficacious at reducing drug use and heavy drinking. When considered together, this research suggests that relapse prevention groups are efficacious in reducing relapse risk, however the relative benefits may differ in the short- vs. long-term.
l
Bowen and colleagues set out to conduct the first randomized, controlled trial which would allow for a scientifically-sound comparison between mindfulness-based relapse prevention, cognitive-behavioral relapse prevention or treatment as usual.
The mindfulness-based relapse prevention intervention consisted of 8 weekly, 2-hour group sessions with 2 therapists. The first few sessions provided patients with a foundation in mindfulness and subsequent sessions focused on mindfulness practices, self-care and social support. The cognitive-behavioral relapse prevention intervention was similar to the mindfulness-based program with respect to treatment dose, environment and expectations (e.g. amount of homework).
Topics included:
The treatment as usual condition was a 12-step abstinence-based open-formal group treatment that consisted primarily of discussions. These groups were held 1-2 times per week for 1.5 hours.
To assess the relative efficacy of mindfulness-based relapse prevention, the researchers compared time to relapse (drug use or heavy drinking) between groups over 1 year. Compared to the 12-step abstinence-based group, the mindfulness and cognitive-behavioral relapse prevention groups showed a 54-59% decreased risk of relapse.
Key Findings Included:
The cognitive-behavioral relapse prevention group was most efficacious in extending time to relapse post-treatment. Both the cognitive-behavioral and the mindfulness-based relapse prevention group showed greater odds of reducing relapse risk as compared to the 12-step abstinence-based group treatment. As time progressed, the treatment condition did not appear to be important in terms of substance use outcomes (6 months) until the 1-year mark at which point the mindfulness-based relapse prevention group appeared to be the most efficacious at reducing drug use and heavy drinking. When considered together, this research suggests that relapse prevention groups are efficacious in reducing relapse risk, however the relative benefits may differ in the short- vs. long-term.